Apr 9, 2020 | All Posts, Controlled Release, Drug Bioavailability, Main Blog |
Extended Release (ER) feasibility in drug delivery continues to be an important challenge for pharmaceutical and biotech drug manufacturers. There are many factors and parameters to consider including dosage form, selecting the appropriate technology process and...
Apr 8, 2020 | All Posts, Controlled Release, Drug Bioavailability, Main Blog |
Identifying and overcoming solubility challenges continues to be an important issue for pharmaceutical and biotech drug manufacturers. Estimates of 70% of new drugs still suffer from solubility issues. As a result, industry has responded with the development of...
Mar 16, 2020 | All Posts, Controlled Release, Main Blog |
The Next Generation of Drug Delivery: Where Are We Headed? The drug delivery technology market continues to grow rapidly from a technology and application standpoint, particularly in the areas of oral, injectable, topical, nasal, ocular, pulmonary, implantable, and...
Mar 3, 2020 | All Posts, Controlled Release, Main Blog |
Decreasing Time-to-Market via Synchrotron Utilization to Discover Stable Formulation Discovering a potent and highly selective API is of course only part of the story of creating a new medicine. Careful consideration of the appropriate dosage form for the patient is...
Sep 13, 2019 | Controlled Release, Drug Bioavailability, Main Blog, Peptide |
Beyond 2020, the global Peptide Therapeutics market is expected to eclipse $42 billion. This dramatic market increase is driven by both growing incidences of cardiovascular and metabolic diseases, and technological enhancements in peptide synthesis that include...
Jul 3, 2019 | Controlled Release, Main Blog, Peptide |
Big Picture Outlook According to markets & Markets, the drug delivery technology market is expected to reach USD $1,669.4 Billion by 2020 from USD $1,179.2 Billion in 2016, growing at a CAGR of 7.2% during the forecast period. Geographically, Asia is projected to...
Recent Comments